The headquarters of Osstem Implant located in western Seoul / NewsisBy Anna J. ParkThe Korea Corporate Governance Improvement (KCGI) has decided to sell its 6.92 percent stake in Osstem Implant during a tender offer launched late last month by a consortium made up of Unison Capital Korea and MBK Partners, according to the activist fund. The tender offer is scheduled to last through Feb. 24. KCGI said Friday that the decision to accept the tender offer is to respect a good faith principle for its fund investors. The consortium of the two private equity companies plan to delist Osstem Implant from the main benchmark KOSPI, if it succeeds in gathering enough stakes during the tender offer.

Source: The Times February 12, 2023 12:24 UTC